Dilatation, Pathologic: Clinical Trials

6 trials for Dilatation, Pathologic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 unknown. 6 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Unknown 6
Phase 22Unknown 2

Follow Dilatation, Pathologic: new trials by email Literature Review of Dilatation, Pathologic trials Research Report on Dilatation, Pathologic

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Corneal Collagen Cross-Linking (CXL) Performed With "Epi-ON" Versus "Epi-OFF" in Eyes With Keratoconus and Other Corneal Ectatic Disorders
Ricrolin+, VEGA UV-A system - Keratoconus, Ectasia
Phase 3UnknownCenter for Sight, Sacramento, CA5502019-03-082019-02-28
Safety and Effectiveness of Corneal Crosslinking (CXL): Keratoconus and Post-Refractive Ectasia
Ricrolin+, Epi-Off - Keratoconus, Ectasia
Phase 3UnknownIcahn School of Medicine at Mount Sinai82016-06-012018-06-07
Corneal Cross-Linking Comparing Variables
Epithelium-On Riboflavin, Epithelium-Off Riboflavin, UV Light - Continuous Beam - Unstable Corneas
Phase 3UnknownCrowd Health Research, LTD5002014-05-012014-03-26
Treatment Study of Frozen Shoulder: Corticosteroid Injection in Joint Versus Wait and See Policy
Triamcinolone Acetonide - Shoulder Capsulitis, Shoulder Adhesive Capsulitis
Phase 3UnknownSatya Pal Sharma1202010-02-012015-05-28
Collagen Cross-Linking for Keratoconus/Ectasia With and Without Intacs
Riboflavin - Keratoconus, Ectasia
Phase 2 / Phase 3UnknownYaron S. Rabinowitz M.D.6002009-01-212018-10-02
Treatment of Keratoconus Using Collagen Cross-Linking
Riboflavin-5-phosphate, Sham cross-linking - Keratoconus
Phase 2 / Phase 3UnknownUniversity at Buffalo1502008-09-012009-02-11

Narrower conditions

Keratoconus (5)  ·  Corneal Diseases (2)  ·  Bursitis (1)

Broader conditions

Pathological Conditions, Anatomical (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Eye Diseases (5)  ·  Corneal Diseases (3)  ·  Joint Diseases (1)  ·  Musculoskeletal Diseases (1)

Interventions

Riboflavin (2)  ·  Corneal Cross-Linking (1)  ·  Flavin Mononucleotide (1)  ·  Iontophoresis (1)  ·  Lubricant Eye Drops (1)  ·  Triamcinolone Acetonide (1)

Sponsors

Center for Sight, Sacramento, CA (1)  ·  Crowd Health Research, LTD (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Satya Pal Sharma (1)  ·  University at Buffalo (1)  ·  Yaron S. Rabinowitz M.D. (1)

Countries

United States (5)  ·  Norway (1)

Top investigators

Anders Barheim, MD PhD (1)  ·  Ezra Maguen, M.D. (1)  ·  James J Reidy, M.D. (1)  ·  James Salz, M.D. (1)  ·  Nancy A Tanchel, MD (1)  ·  Penny A Asbell, MD (1)  ·  Ronald Gaster, MD (1)  ·  Yaron S Rabinowitz, M.D. (1)  ·  Yuri Oleynikov, M.D. PhD (1)

Results publications

PMID 12719068, PMID 16565005, PMID 16765803, PMID 16900027, PMID 16952090, PMID 17457183, PMID 17457184, PMID 17531694, PMID 17720054, PMID 27229470, PMID 28865441

NIH funding

2008 (1)